Xiaomai Wu

618 total citations
19 papers, 155 citations indexed

About

Xiaomai Wu is a scholar working on Infectious Diseases, Oncology and Neurology. According to data from OpenAlex, Xiaomai Wu has authored 19 papers receiving a total of 155 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Oncology and 5 papers in Neurology. Recurrent topics in Xiaomai Wu's work include Lung Cancer Research Studies (6 papers), Long-Term Effects of COVID-19 (5 papers) and COVID-19 Clinical Research Studies (4 papers). Xiaomai Wu is often cited by papers focused on Lung Cancer Research Studies (6 papers), Long-Term Effects of COVID-19 (5 papers) and COVID-19 Clinical Research Studies (4 papers). Xiaomai Wu collaborates with scholars based in China and United States. Xiaomai Wu's co-authors include Dongqing Lv, Guixian Wu, Ling Lin, Xi Chen, Jian Lin, Xiaodan Wang, Haihua Yang, Jiao Sun, Zhi Lin and Xi Chen and has published in prestigious journals such as Annals of Oncology, Emerging infectious diseases and BioMed Research International.

In The Last Decade

Xiaomai Wu

19 papers receiving 154 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaomai Wu China 7 71 53 36 36 27 19 155
Simon Bessis France 7 57 0.8× 40 0.8× 23 0.6× 31 0.9× 16 0.6× 16 148
И. В. Шлык Russia 6 71 1.0× 34 0.6× 38 1.1× 17 0.5× 11 0.4× 46 158
Claudio Acevedo Switzerland 8 87 1.2× 31 0.6× 58 1.6× 36 1.0× 15 0.6× 11 204
Guido Siccardi Italy 6 102 1.4× 48 0.9× 56 1.6× 15 0.4× 13 0.5× 9 163
Ilduara Pintos Spain 7 78 1.1× 37 0.7× 43 1.2× 7 0.2× 13 0.5× 19 138
Pınar Aysert Yıldız Türkiye 7 126 1.8× 66 1.2× 35 1.0× 10 0.3× 10 0.4× 20 217
Liron Sheena Israel 6 79 1.1× 31 0.6× 44 1.2× 14 0.4× 5 0.2× 7 200
A Vâţă Romania 7 69 1.0× 20 0.4× 51 1.4× 11 0.3× 6 0.2× 58 148
April Yarbrough United States 7 79 1.1× 14 0.3× 37 1.0× 22 0.6× 10 0.4× 11 132
Hardik Dineshbhai Desai India 8 59 0.8× 41 0.8× 51 1.4× 12 0.3× 12 0.4× 52 200

Countries citing papers authored by Xiaomai Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaomai Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomai Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomai Wu more than expected).

Fields of papers citing papers by Xiaomai Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomai Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomai Wu. The network helps show where Xiaomai Wu may publish in the future.

Co-authorship network of co-authors of Xiaomai Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomai Wu. A scholar is included among the top collaborators of Xiaomai Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomai Wu. Xiaomai Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wu, Guixian, Ling Lin, Chao Zhou, et al.. (2024). Anlotinib plus oral fluoropyrimidine S-1 in refractory or relapsed small-cell lung cancer (SALTER TRIAL): a multicenter, single-arm, phase II trial. BMC Cancer. 24(1). 1182–1182. 2 indexed citations
2.
3.
Zhou, Kai, Hongbo Chi, Jing Wang, et al.. (2022). Physical condition, psychological status, and posttraumatic stress disorder among recovered COVID-19 subjects: A mediation analysis. Frontiers in Psychiatry. 13. 918679–918679. 1 indexed citations
4.
Chi, Hongbo, Kai Zhou, Jiaqin Xu, et al.. (2022). The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: A longitudinal cohort study. International Immunopharmacology. 110. 109019–109019. 5 indexed citations
5.
Wu, Guixian, Jing Huang, Ling Lin, et al.. (2022). Toripalimab and Anlotinib as a Maintenance Treatment for Extensive-Stage Small-Cell Lung Cancer: A Case Report. Immunotherapy. 14(13). 1007–1013. 4 indexed citations
6.
7.
Lv, Dongqing, et al.. (2021). P48.07 Synergistic Antitumor Effects of Anlotinib Combination With Oral 5-Fluorouracil S-1 in Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S502–S502. 1 indexed citations
8.
9.
Zhang, Chao, Xiaodan Wang, Xi Chen, et al.. (2020). Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China. Annals of Translational Medicine. 8(8). 547–547. 25 indexed citations
10.
Zhou, Chao, Haihua Yang, Hailing Xu, et al.. (2020). Relationship between chest CT manifestations and immune response in COVID-19 patients. International Journal of Infectious Diseases. 98. 125–129. 19 indexed citations
11.
Zhou, Hua, Qing Yang, Lisha Shen, et al.. (2020). Seawater-Associated Highly Pathogenic Francisella hispaniensis Infections Causing Multiple Organ Failure. Emerging infectious diseases. 26(10). 2424–2428. 6 indexed citations
12.
Lv, Dongqing, Xi Chen, Xiaodan Wang, et al.. (2020). Pulmonary function of patients with 2019 novel coronavirus induced-pneumonia: a retrospective cohort study. Annals of Palliative Medicine. 9(5). 3447–3452. 30 indexed citations
13.
Lin, Jian, et al.. (2019). Retropharyngeal abscess presenting as acute airway obstruction in a 66-year-old woman: A case report. World Journal of Clinical Cases. 7(22). 3838–3843. 6 indexed citations
14.
Lin, Jian, et al.. (2019). Bacterial etiology in early re-admission patients with acute exacerbation of chronic obstructive pulmonary disease. African Health Sciences. 19(2). 2073–2073. 2 indexed citations
15.
Lv, Dongqing, et al.. (2019). Concurrent infection with Talaromyces marneffei and Cryptococcus neoformans in a patient without HIV infection. Experimental and Therapeutic Medicine. 19(1). 160–164. 8 indexed citations
16.
Lin, Ling, et al.. (2016). A rare fatal case of a novel bunyavirus-associated hemophagocytic lymphohistiocytosis. The Journal of Infection in Developing Countries. 10(5). 533–536. 1 indexed citations
17.
18.
Lin, Jian, et al.. (2013). Risk factors associated with chronic obstructive pulmonary disease early readmission. Current Medical Research and Opinion. 30(2). 315–320. 15 indexed citations
19.
Wu, Xiaomai, et al.. (2012). [Association between human beta defensin-1 single nucleotide polymorphisms and susceptibility to pulmonary tuberculosis].. PubMed. 46(10). 912–5. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simon Bessis Breakdown of academic impact, for papers by И. В. Шлык Breakdown of academic impact, for papers by Claudio Acevedo Breakdown of academic impact, for papers by Guido Siccardi Breakdown of academic impact, for papers by Ilduara Pintos Breakdown of academic impact, for papers by Pınar Aysert Yıldız Breakdown of academic impact, for papers by Liron Sheena Breakdown of academic impact, for papers by A Vâţă Breakdown of academic impact, for papers by April Yarbrough Breakdown of academic impact, for papers by Hardik Dineshbhai Desai
Rankless by CCL
2026